Emergent Biosolutions reported $383M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 158.93M 14.4M
Akebia Therapeutics AKBA:US $ 79.76M 37.48M
Alnylam Pharmaceuticals ALNY:US $ 366.71M 2.89M
Amarin AMRN:US 145.72M 2.21M
Ani Pharmaceuticals ANIP:US $ 64.18M 12.7M
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Chimerix CMRX:US 18.21M 80.68M
Coherus Biosciences CHRS:US $ 111.81M 138.59M
Emergent Biosolutions EBS:US $ 383M 135.4M
Exelixis EXEL:US $ 262.17M 12.67M
Flexion Therapeutics FLXN:US $ 45.06M 2.67M
Glaxosmithkline GSK:US 6.42B 692M
Heron Therapeutics HRTX:US $ 82.91M 10.78M
Immunogen IMGN:US $ 44.32M 305K
Intercept Pharmaceuticals ICPT:US $ 95.82M 15.19M
Ironwood Pharmaceuticals IRWD:US $ 38.93M 4.51M
JAZZ PHA JAZZ:US $ 821.4M 375.94M
Lexicon Pharmaceuticals LXRX:US 18.19M 2.67M
Lonza Group LONN:SW 2.22B 1.07B
Merk MRK:US $ 9905M 839M
Moderna Inc MRNA:US 1.29B 621M
Myriad Genetics MYGN:US $ 210.2M 9.6M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Opko Health OPK:US $ 436.84M 69.89M
Pacira Pharmaceuticals PCRX:US $ 100.75M 1.16M
Pfizer PFE:US $ 13063M 3998M
Ptc Therapeutics PTCT:US $ 215.17M 921K
Sarepta Therapeutics SRPT:US $ 331.66M 32.87M
Seattle Genetics SGEN:US $ 478.08M 23.68M
Teva Pharmaceutical Industries TEVA:US 3.33B 220M
United Therapeutics UTHR:US $ 226.6M 217.3M
Vanda Pharmaceuticals VNDA:US $ 55.53M 3.2M
Xoma XOMA:US $ 4.26M 2.54M